Showing results (331-340 of 390) with videos related to
Sort By:
Pageof 39
Epilepsia|November 7, 2019
Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational studyJoyce Y Wu, Monisha Goyal, Jurriaan M Peters, et al.Journal of Neurology|November 6, 2021
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.Journal of Neurology|August 8, 2022
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx studyAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.The Lancet. Neurology|September 22, 2023
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trialAnthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 16, 2015
Placebo-controlled study in neuromyelitis optica-Ethical and design considerationsBruce Ac Cree, Jeffrey L Bennett, Mark Sheehan, et al.Neurology|June 25, 2003
A randomized controlled study of the acute and chronic effects of cooling therapy for MSSteven R Schwid, Mary D Petrie, Ronald Murray, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled TrialPuja P Khanna, Dinesh Khanna, Gary Cutter, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 9, 2024
Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis: Secondary, exploratory analysis of data from the CogEx trialRobert W Motl, Brian M Sandroff, Roberto S Hernandez, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2023
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorderOrhan Aktas, Hans-Peter Hartung, Michael A Smith, et al.Pageof 39